Alle Storys
Folgen
Keine Story von Avantium Technologies B.V. mehr verpassen.

Avantium Technologies B.V.

Due to Adverse Market Conditions Avantium Withdraws its Initial Public Offering

Amsterdam, the Netherlands, November 15 (ots/PRNewswire)

Avantium, a leading technology company in the area of advanced
high-throughput R&D, withdraws its Initial Public Offering ("IPO")
planned for 16 November 2007 due to adverse markets. Avantium will
continue implementing its communicated strategy and closely monitor
the development of the capital markets.
Tom van Aken, CEO of Avantium, said: "We have been very encouraged
by the positive reactions of institutional and retail investors to
our company and strategy. However, Avantium and its shareholders have
decided not to proceed with the planned IPO at this stage because of
sharply declining market conditions."
Company overview
Avantium, established as a spin-off from Royal Dutch Shell in
2000, has developed advanced high-throughput R&D technology. Its
proprietary technology enables the company to conduct many automated
experiments in parallel on a very small scale, providing fast and
cost effective research at superior success rates. Avantium has
demonstrated the validity and commercial viability of its unique,
patented technology and expertise by providing R&D services and tools
to its clients in the energy, chemicals and pharmaceutical
industries. The company services more than 70 companies worldwide,
including many market leaders such as BP, Royal Dutch Shell, Sasol,
Pfizer, Boehringer Ingelheim and GlaxoSmithKline. Building on its
track record and proven technology, Avantium plans to advance its
exciting product development programs in the fields of next
generation biofuels and improved forms of existing drugs.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION INTO OR IN THE UNITED
STATES, AUSTRALIA, CANADA AND JAPAN.

Contact:

For more information about this press release please contact:
Citigate First Financial, José Tijssen, Phone: +31(0)6-551-237-26,
Email: Jose.Tijssen@citigateff.nl

Weitere Storys: Avantium Technologies B.V.
Weitere Storys: Avantium Technologies B.V.
  • 05.11.2007 – 08:06

    Avantium Launches Initial Public Offering on Euronext Amsterdam

    Amsterdam, November 5 (ots/PRNewswire) - - Highlights - Offer Price Expected to be in the Range of EUR12.50 to EUR16.00 Per Share - Offer Size Between EUR20 Million and EUR30 Million - Subscription Starts Today, 5 November 2007, and is Expected to End on 15 November 2007 - Trading on Eurolist by Euronext Amsterdam Expected to Commence on or About 16 November 2007 Avantium, a leading technology ...

  • 31.10.2007 – 09:09

    Avantium to Deliver Flowrence(TM) Systems to Shell

    Amsterdam (ots/PRNewswire) - Avantium Technologies announced today that they have signed an agreement with CRI/Criterion Inc. to enable the sale and delivery of multiple Avantium Flowrence(TM) systems. CRI/Criterion, a catalyst technology company within the Royal Dutch Shell group, is a part of a group of affiliated companies that are leading providers of catalysts, process technologies and catalyst services for a ...

  • 22.10.2007 – 08:05

    Avantium Intends to List on Euronext Amsterdam

    Amsterdam (ots/PRNewswire) - - Not for release, distribution or publication into or in the United States, Australia, Canada and Japan. - Positive Results With Next Generation Biofuels Trigger IPO Plans Avantium, a leading technology company in the area of advanced high-throughput R&D, announces its intention to raise new funds through an initial public offering (the "IPO") and to apply for a listing on ...